Marine Biomedical is an Australian biomaterials company based in Western Australia, developing and manufacturing next-generation, marine-derived solutions for bone regeneration.

Our mission is to unlock the potential of Australia’s marine environment- particularly the pristine waters of the Kimberley coast- to deliver innovative, sustainable medical technologies that improve patient outcomes globally.

At the core of our platform is our proprietary technology, PearlBone™- a natural bone graft substitute derived from nacre (mother of pearl). Sourced from the historic pearling industry in Broome, PearlBone™ represents a unique convergence of sustainability, advanced materials science, and clinical innovation. Once the source of up to 80% of the world’s mother of pearl, Broome’s rich marine heritage now underpins a new frontier in regenerative medicine.

Marine Biomedical is advancing PearlBone™ through rigorous research, development, and regulatory pathways, with applications across orthopaedic and dental indications. The material’s unique structure supports bone regeneration, positioning it as a promising alternative in a growing global market for bone graft substitutes.

We are building a globally impactful Australian innovation- translating marine-derived biomaterials into real-world healthcare solutions - and welcome collaboration with partners who share our vision for advancing regenerative medicine.

Marine Biomedical

Org chart

Teams

Offices